CN106176999A - A kind of Chinese medicine treating acute myelitis - Google Patents
A kind of Chinese medicine treating acute myelitis Download PDFInfo
- Publication number
- CN106176999A CN106176999A CN201610712562.8A CN201610712562A CN106176999A CN 106176999 A CN106176999 A CN 106176999A CN 201610712562 A CN201610712562 A CN 201610712562A CN 106176999 A CN106176999 A CN 106176999A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- chinese medicine
- treating acute
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine treating acute myelitis, medicine including following parts by weight is prepared from: the hammer flower of 25 35 parts by weight, the Cortex Albiziae of 15 25 parts by weight, the Radix Ranunculi Ternati of 20 30 parts by weight, the Rhizoma Chuanxiong of 20 30 parts by weight, the Hirudo of 5 10 parts by weight, the Cornu Cervi of 10 20 parts by weight, the Radix Glycyrrhizae of 5 10 parts by weight.The present invention forms with pure traditional Chinese medicine, and scientific formulation is reasonable, and configuration is simple, has no side effect, and curative effect is short, instant effect, difference and the Therapeutic Principle in the past treating acute myelitis, have heat-clearing and toxic substances removing, invigorate blood circulation, calm the nerves, subside a swelling, blood stasis dispelling, the effect of the relaxing muscles and tendons that stimulates the menstrual flow.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine treating acute myelitis.
Background technology
Acute myelitis (acute myelitis) refers to that various autoimmune response (induces after mostly being infection, Ge Biewei
After vaccination or hidden source property reason) caused by acute transverse myelitis sexually revise, also known as acute transverse myelitis, be to face
Modal a kind of myelitis on bed.This disease refer to nonspecific inflammation cause spinal cord acute Progressive symmetric erythrokeratodermia Demyelmating disease become or
Necrosis, pathological changes is typically restricted to several sections of spinal cord, and main pathological change is that myelin swelling, depigmentation, peripheral lymphocyte are notable
Hypertrophy, axonal degeneration, perivascular inflammation cellular infiltration.Breast marrow is the most often got involved, with disease damage quadriplegia below horizontal, conductive beam
Property sensory disturbance and urine and stool obstacle are Clinical symptoms.Directly the cause of disease is still not clear, and most of patients is before there is cord symptom 1～4
Have viral infection symptoms or the vaccination histories such as heating, upper respiratory tract infection, diarrhoea week, including influenza, measles, chickenpox, rubella,
Many infectants such as mumps and Epstein-Barr virus, cytomegalovirus, mycoplasma all may be relevant with primary disease, but its brain ridge
Liquid does not detects in antiviral antibody, spinal cord and cerebrospinal fluid and does not isolates virus, thus it is speculated that may be with virus postinfectious autoimmune reaction
Relevant, not caused by direct infection, for non-infectious inflammation myelitis.
The pathological change of acute myelitis can involve any sections of spinal cord in the vertical, but with breast marrow (T3～5) the most
Common, account for the 75% of whole patient, may be longer with chest section spinal cord, how relevant impaired chance is, and another kind of viewpoint thinks that T4 is
Vascularity junctional area, easily occurs ischemia to be damaged by inflammation, transversely can involve the ash of spinal cord, white matter, it is possible to involve
Spinal meninges and nerve root, majority of cases is based on spinal pia mater, spinal cord periphery white matter, and minority is based on central gray substance, and disease damage can be office
Stove, transverse or many stoves amalgamation.Damaged part spinal cord swelling seen from perusal, spinal pia mater is congested or has inflammatory exudate attached
, seen from tangent plane, cinereum matter boundary is unclear, can have petechial hemorrhage.Vasodilation, hyperemia in spinal pia mater seen under microscope and marrow,
Periangiitis cellular infiltration, based on lymphocyte and plasma cell.Neuron swelling in grey matter, Nissl body are dissolved, karyon
Off normal, and may occur in which cell fragmentation, dissolve, disappear；Myelin swelling, degeneration and depigmentation seen from white matter.The pathological change of primary disease because of
State of an illness weight and different, the lighter can only occur that periangiitis cell oozes out and lucent area occurs around myelinoclasis, blood vessel, weight
Person's pathological changes can be fused into lamellar or in cavity shape, often accompanies microglia hypertrophy and swallows lipoids and become gitter cell, dissipating
It is in focus, patients with terminal visual solubilization district proliferation of astrocytes, and extends with the course of disease and gradually form fibrous scar,
Myelatrophy.Membrane of spinal cord often has primary or secondary to get involved, and shows as vascular endothelial cell swelling, and perivascular inflammatory cell oozes
Go out, increase for vascular permeability in early days, then can cause vascular occlusion because of ischemia and blood vessel endothelium degeneration late period.Acute myelitis at present
Therapeutic Method based on drug injection, but this Therapeutic Method is cured the symptoms, not the disease, it is impossible to fundamentally solve the asking of patient
Topic, treats Chinese medicine the most all poor effect of acute myelitis at present, and in its prescription, the use Chinese medicine of bulk deposition, has seemed very
Good curative effect, but the financial burden of patient that on the one hand medicine of big prescription increases the weight of, it is often more important that making of big prescription medicine
By the toxic and side effects increased the weight of between prescription Chinese medicine, bring unnecessary potential safety hazard to patient.
Summary of the invention
For the deficiencies in the prior art, the present invention provides a kind of low cost, instant effect, and cure rate is high, has no side effect
The Chinese medicine for the treatment of acute myelitis.
The technical scheme is that and be achieved in that: a kind of Chinese medicine treating acute myelitis, including following parts by weight
Raw material of Chinese medicine be prepared from: the hammer of 25-35 parts by weight flower, the Cortex Albiziae of 15-25 parts by weight, 20-30 parts by weight
Radix Ranunculi Ternati, the Rhizoma Chuanxiong of 20-30 parts by weight, the Hirudo of 5-10 parts by weight, the Cornu Cervi of 10-20 parts by weight, 5-10 weight
The Radix Glycyrrhizae of number.
Technical scheme can be achieved in that
A kind of Chinese medicine treating acute myelitis, the medicine including following parts by weight is prepared from: 30 parts by weight
Hammer flower, the Cortex Albiziae of 20 parts by weight, the Radix Ranunculi Ternati of 25 parts by weight, the Rhizoma Chuanxiong of 25 parts by weight, the water of 6 parts by weight
Trematodiasis, the Cornu Cervi of 15 parts by weight, the Radix Glycyrrhizae of 8 parts by weight.
Each raw material is mixed by the present invention, is ground into fine powder, directly takes, and three times a day, each 2-3 gram, warm water takes.
The course for the treatment of: 10 days be a course for the treatment of, the 2-6 course for the treatment of need to be taken.
The pharmacology of each concrete ingredient is as follows:
Hammer flower: bitter, cold；Heat-clearing and toxic substances removing, eliminating carbuncle, stimulating milk secretion, relaxing muscles and tendons is promoted blood circulation.
Cortex Albiziae: sweet, flat；Resolving stagnation for tranquilization, promoting blood circulation and detumescence.
Radix Ranunculi Ternati: sweet, acrid, warm；Eliminating stagnation, detumescence.
Rhizoma Chuanxiong: pungent, temperature；Blood-activating and qi-promoting, wind-expelling pain-stopping.
Hirudo: salty, bitter, flat；Slightly poisonous；Removing blood stasis, removing blood stasis, stimulates the menstrual flow.
Cornu Cervi: salty, temperature；The kidney warming sun, bone and muscle strengthening, promoting the circulation of blood is subsided a swelling.
Radix Glycyrrhizae: sweet, flat；Invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.
The function of the present invention and curing mainly: hammer flower, Radix Glycyrrhizae heat-clearing and toxic substances removing in the present invention；Cortex Albiziae, Cornu Cervi promoting blood circulation and detumescence peace
God；Rhizoma Chuanxiong, Hirudo blood circulation promoting and blood stasis dispelling；Hammer is spent, Hirudo stimulates the menstrual flow relaxing muscles and tendons；Radix Glycyrrhizae invigorating the spleen and replenishing QI, coordinating the actions of various ingredients in a prescription, heat clearing away solution played altogether by all medicines
Poison, invigorate blood circulation, calm the nerves, subside a swelling, blood stasis dispelling, the effect of the relaxing muscles and tendons that stimulates the menstrual flow.
Beneficial effects of the present invention: the present invention forms with pure traditional Chinese medicine, scientific formulation is reasonable, and configuration is simple, nontoxic pair
Effect, curative effect is short, instant effect, difference and the Therapeutic Principle in the past treating acute myelitis, have heat-clearing and toxic substances removing, invigorate blood circulation, calm the nerves,
Detumescence, blood stasis dispelling, the effect of the relaxing muscles and tendons that stimulates the menstrual flow.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further details:
Embodiment 1: a kind of Chinese medicine treating acute myelitis, the medicine including following weight grams is prepared from: 25 grams
Hammer flower, the Cortex Albiziae of 15 grams, the Radix Ranunculi Ternati of 20 grams, the Rhizoma Chuanxiong of 20 grams, the Hirudo of 5 grams, the Cornu Cervi of 10 grams, the Radix Glycyrrhizae of 5 grams.
Embodiment 2: a kind of Chinese medicine treating acute myelitis, the medicine including following weight grams is prepared from: 35 grams
Hammer flower, the Cortex Albiziae of 25 grams, the Radix Ranunculi Ternati of 30 grams, the Rhizoma Chuanxiong of 30 grams, the Hirudo of 10 grams, the Cornu Cervi of 20 grams, 10 grams sweet
Grass.
Embodiment 3: a kind of Chinese medicine treating acute myelitis, the medicine including following weight grams is prepared from: 30 grams
Hammer flower, the Cortex Albiziae of 20 grams, the Radix Ranunculi Ternati of 25 grams, the Rhizoma Chuanxiong of 25 grams, the Hirudo of 6 grams, the Cornu Cervi of 15 grams, the Radix Glycyrrhizae of 8 grams.
Embodiment 4: a kind of Chinese medicine treating acute myelitis, the medicine including following weight grams is prepared from: 33 grams
Hammer flower, the Cortex Albiziae of 16 grams, the Radix Ranunculi Ternati of 28 grams, the Rhizoma Chuanxiong of 22 grams, the Hirudo of 7 grams, the Cornu Cervi of 14 grams, the Radix Glycyrrhizae of 7 grams.
Each raw material is mixed by Chinese medicine in embodiment 1-4 in the preparation, is ground into fine powder, directly takes, three times a day, often
Secondary 2-3 gram, take with warm water.
The present invention is not limited to above-mentioned preferred forms, anyone draw under the enlightenment of the present invention other any with
Product as the present invention is same or like, within all falling within protection scope of the present invention.
The result of clinical observation of the present invention is as follows:
Effective cure rate statistics of the Chinese medicine of the present invention, criterion of therapeutical effect is as follows:
Cure: the symptom of bilateral, sign disappear；
Effective: the symptom of bilateral, sign make moderate progress；
Invalid: the symptom of bilateral, sign are not improved.
The present invention treats patient's totally 57 example participating in statistics, wherein: 48 examples of fully recovering, effective 6 examples, invalid 3 examples, total effective rate
Reach 94%.
Model case:
Becoming certain, female, 31 years old, low grade fever, numb limbs and tense tendons were weak, by here Drug therapy, fully recovered after two weeks.
Cattle, man, 18 years old, cerebral ridge liquid lymphocyte increased, IgG synthetic ratio raises, and diseased region radiculalgia, by me
Place's Drug therapy, fully recovers after two weeks.
Week certain, man, 39 years old, sudden onset when being engaged in agriculture of being in, be paralyzed in bed, by here treat, within 20 days, the state of an illness substantially changes
Kind, fully recover after one and a half months.
Claims (2)
1. the Chinese medicine treating acute myelitis, it is characterised in that: include that the medicine of following parts by weight is prepared from: 25-
The hammer flower of 35 parts by weight, the Cortex Albiziae of 15-25 parts by weight, the Radix Ranunculi Ternati of 20-30 parts by weight, 20-30 parts by weight
Rhizoma Chuanxiong, the Hirudo of 5-10 parts by weight, the Cornu Cervi of 10-20 parts by weight.The Radix Glycyrrhizae of 5-10 parts by weight.
A kind of Chinese medicine treating acute myelitis the most according to claim 1, it is characterised in that: include following parts by weight
Medicine be prepared from: the hammer of 30 parts by weight flower, the Cortex Albiziae of 20 parts by weight, the Radix Ranunculi Ternati of 25 parts by weight, 25 weights
The Rhizoma Chuanxiong of amount number, the Hirudo of 6 parts by weight, the Cornu Cervi of 15 parts by weight, the Radix Glycyrrhizae of 8 parts by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610712562.8A CN106176999A (en) | 2016-08-24 | 2016-08-24 | A kind of Chinese medicine treating acute myelitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610712562.8A CN106176999A (en) | 2016-08-24 | 2016-08-24 | A kind of Chinese medicine treating acute myelitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106176999A true CN106176999A (en) | 2016-12-07 |
Family
ID=57524876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610712562.8A Pending CN106176999A (en) | 2016-08-24 | 2016-08-24 | A kind of Chinese medicine treating acute myelitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106176999A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105031441A (en) * | 2015-06-26 | 2015-11-11 | 吴强 | Medicine for treating ankylosing spondylitis and preparation method of medicine |
| CN105596973A (en) * | 2015-10-09 | 2016-05-25 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for treating acute myelitis |
-
2016
- 2016-08-24 CN CN201610712562.8A patent/CN106176999A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105031441A (en) * | 2015-06-26 | 2015-11-11 | 吴强 | Medicine for treating ankylosing spondylitis and preparation method of medicine |
| CN105596973A (en) * | 2015-10-09 | 2016-05-25 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for treating acute myelitis |
Non-Patent Citations (1)
| Title |
|---|
| 王增武: "《脑血管病临床检查与治疗》", 30 June 2014, 中国出版集团世界图书出版公司 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101804190B (en) | Tongbi cream for relieving rigidity of muscles and promoting blood circulation and preparation method thereof | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN103893702B (en) | A kind of Chinese medicine composition for the treatment of hyperosteogeny and preparation method thereof | |
| CN103861046A (en) | Traditional Chinese medicine for treating prosopalgia | |
| CN103520579A (en) | Medicinal liquor used for treating lumbocrural pain, hyperostosis and sciatica | |
| CN103285200B (en) | Traditional Chinese medicine for treating multiple osteopathies | |
| CN104524208A (en) | Medicament for treatment of sciatica and preparation method | |
| CN103751626B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of sciatica | |
| CN103417631A (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN102743554B (en) | Externally applied plaster treating rheumatic arthralgia | |
| CN104083568A (en) | Miao medicine plaster for ostealgia and preparation method thereof | |
| CN104337935B (en) | A kind of Ginkgo Leaf Chinese traditional compound medicine and preparation method treating osteoporosis | |
| CN104306475B (en) | The medicine of a kind of mud stick treatment bone joint pain and processing method thereof | |
| CN103735851B (en) | A kind of Chinese medicine preparation for the treatment of fracture | |
| CN103550446B (en) | Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition | |
| CN103202641B (en) | A kind of cervical vertebrae correction therapeutic medicine-filled pillow | |
| CN106176999A (en) | A kind of Chinese medicine treating acute myelitis | |
| CN102764355B (en) | Traditional Chinese medicine composite for curing femoral head necrosis | |
| CN101700395B (en) | Ointment for curing hyperosteogeny | |
| CN104758527A (en) | Traditional Chinese medicine composition for treating pain in waists and legs | |
| CN104771432A (en) | Traditional Chinese medicine for treating fracture | |
| CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
| CN102512505B (en) | Chinese patent medicine for treating bone spur | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
| CN104524065A (en) | Traditional Chinese medicine preparation for treating femoral head necrosis and preparation method of traditional Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161207 |